Interleukin-15 blocks apoptosis and induces proliferation of the human myeloma cell line OH-2 and freshly isolated myeloma cells

British Journal of Haematology

Volumn 106, Issue 1, 1999, Pages 28-34

  Hjorth Hansen, Henrik ^a   Waage, Anders ^a   Börset, Magne ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Apoptosis; Cytokine; Interleukin 15; Myeloma; Proliferation

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 6;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; GROWTH REGULATION; HUMAN; HUMAN CELL; MYELOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL DIVISION; HUMANS; INTERLEUKIN-15; MULTIPLE MYELOMA; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0032865647     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01510.x     Document Type: Article

References (46)

1. Adunyah, S.E., Wheeler, B.J. & Cooper, R.S. (1997) Evidence for the involvement of LCK and MAP kinase (ERK-1) in the signal transduction mechanism of interleukin-15. Biochemical and Biophysical Research Communications, 232, 754-758.
2. Agostini, C., Trentin, L., Facco, M., Sancetta, R., Cerutti, A., Tassinari, C., Cimarosto, L., Adami, F., Cipriani, A., Zambello, R. & Semenzato, G. (1996) Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. Journal of Immunology, 157, 910-918.
3. Anderson, K.C., Jones, R.M., Morimoto, C., Leavitt, P. & Barut, B.A. (1989) Response patterns of purified myeloma cells to hematopoietic growth factors. Blood, 73, 1915-1924.
4. Anonymous (1995) Construction of immobilized cDNA libraries for multiple RT-PCR amplifications. Biomagnetic Techniques in Molecular Biology, pp. 43 and 64. Dynal AS, Oslo.
5. Barzegar, C., Meazza, R., Pereno, R., Pottin-Clemenceau, C., Scudeletti, M., Brouty-Boye, D., Doucet, C., Taoufik, Y., Ritz, J., Musselli, C., Mishal, Z., Jasmin, C., Indiveri, F., Ferrini, S. & Azzarone, B. (1998) IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops. Oncogene, 16, 2503-2512.
6. Bataille, R., Barlogie, B., Lu, Z.Y., Rossi, J.F., Lavabre Bertrand, T., Beck, T., Wijdenes, J., Brochier, J. & Klein, B. (1995) Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma. Blood, 86, 685-691.
7. Börset, M., Helseth, E., Naume, B. & Waage, A. (1993) Lack of IL-1 secretion from human myeloma cells highly purified by immunomagnetic separation. British Journal of Haematology, 85, 446-451.
8. Börset, M., Hjorth-Hansen, H., Seidel, C., Sundan, A. & Waage, A. (1996) Hepatocyte growth factor and its receptor c-met in multiple myeloma. Blood, 88, 3998-4004.
9. Börset, M., Waage, A., Brekke, O.L. & Helseth, E. (1994) TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma cell line. European Journal of Haematology, 53, 31-37.
10. Bulfone Paus, S., Ungureanu, D., Pohl, T., Lindner, G., Paus, R., Ruckert, R., Krause, H. & Kunzendorf, U. (1997) Interleukin-15 protects from lethal apoptosis in vivo. Nature Medicine, 3, 1124-1128.
11. Carson, W.E., Fehniger, T.A., Haldar, S., Eckhert, K., Lindemann, M.J., Lai, C.F., Croce, C.M., Baumann, H. & Caligiuri, M.A. (1997) A potential role for interleukin-15 in the regulation of human natural killer cell survival. Journal of Clinical Investigation, 99, 937-943.
12. Döbbeling, U., Dummer, R., Laine, E., Potoczna, N., Qin, J.Z. & Burg, G. (1998) Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells. Blood, 92, 252-258.
13. Giri, J.G., Kumaki, S., Ahdieh, M., Friend, D.J., Loomis, A., Shanebeck, K., DuBose, R., Cosman, D., Park, L.S. & Anderson, D.M. (1995) Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO Journal, 14, 3654-3663.
14. Grabstein, K.H., Eisenman, J., Shanebeck, K., Rauch, C., Srinivasan, S., Fung, V., Beers, C., Richardson, J., Schoenborn, M.A., Ahdieh, M., Johnson, L., Alderson, M.R., Watson, J.D., Anderson, D.M. & Giri, J.G. (1994) Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science, 264, 965-968.
15. Gu, Z.J., Costes, V., Lu, Z.Y., Zhang, X.G., Pitard, V., Moreau, J.F., Bataille, R., Wijdenes, J., Rossi, J.F. & Klein, B. (1996) Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop. Blood, 88, 3972-3986.
16. Hallek, M., Bergsagel, P.L. & Anderson, K.C. (1998) Multiple myeloma: increasing evidence for a multistep transformation process. Blood, 91, 3-21.
17. Jelinek, D.F., Witzig, T.E. & Arendt, B.K. (1997) A role for insulin-like growth factor in the regulation of IL-6-responsive human myeloma cell line growth. Journal of Immunology, 159, 487-496.
18. Johnston, J.A., Bacon, C.M., Finbloom, D.S., Rees, R.C., Kaplan, D., Shibuya, K., Ortaldo, J.R., Gupta, S., Chen, Y.Q., Giri, J.D. & O'Shea, J.J. (1995) Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proceedings of the National Academy of Sciences of the United States of America, 92, 8705-8709.
19. Kakumu, S., Okumura, A., Ishikawa, T., Yano, M., Enomoto, A., Nishimura, H., Yoshioka, K. & Yoshika, Y. (1997) Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease. Clinical and Experimental Immunology, 109, 458-463.
20. Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., Kuramoto, A. & Kishimoto, T. (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature, 332, 83-85.
21. Kawano, M.M., Mihara, K., Huang, N., Tsujimoto, T. & Kuramoto, A. (1995) Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood, 85, 487-494.
22. Kim, Y.S., Maslinski, W., Zheng, X.X., Stevens, A.C., Li, X.C., Tesch, G.H., Kelley, V.R. & Strom, T.B. (1998) Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fe gamma2a protein blocks delayed-type hypersensitivity. Journal of Immunology, 160, 5742-5748.
23. Kirman, I. & Nielsen, O.H. (1996) Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. American Journal of Gastroenterology, 91, 1789-1794.
24. Klein, B., Zhang, X.G., Jourdan, M., Content, J., Houssiau, F., Aarden, L., Piechaczyk, M. & Bataille, R. (1989) Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood, 73, 517-526.
25. Klein, B. (1995) Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma. Seminars in Hematology, 32, 4-19.
26. Li, X.C., Roy-Chaudhury, P., Hancock, W.W., Manfro, R., Zand, M.S., Li, Y.S., Zheng, X.X., Nickerson, P.W., Steiger, J., Malek, T.R. & Strom, T.B. (1998) IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection. Journal of Immunology, 161, 890-896.
27. Lollini, P.L., Palmieri, G., De Giovanni, C., Landuzzi, L., Nicoletti, G., Rossi, I., Griffoni, C., Frabetti, F., Scotlandi, K., Benini, S., Baldini, N., Santoni, A. & Nanni, P. (1997) Expression of interleukin 15 (IL-15) in human rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma. International Journal of Cancer, 71, 732-736.
28. Lu, Z.Y., Gu, Z.J., Zhang, X.G., Wijdenes, J., Neddermann, P., Rossi, J.E. & Klein, B. (1995) Interleukin-10 induces interleukin-11 responsiveness in human myeloma cell lines. FEBS Letters, 377, 515-518.
29. Meazza, R., Gaggero, A., Neglia, F., Basso, S., Sforzini, S., Pereno, R., Azzarone, B. & Ferrini, S. (1997) Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion: role of different signal peptides. European Journal of Immunology, 27, 1049-1054.
30. Mohamadzadeh, M., Takashima, A., Dougherty, I., Knop, J., Bergstresser, P.R. & Cruz, P.D., Jr (1995) Ultraviolet B radiation up-regulates the expression of IL-15 in human skin. Journal of Immunology, 155, 4492-4496.
31. Ogasawara, K., Hida, S., Azimi, N., Tagaya, Y., Sato, T., Yokochi-Fukuda, T., Waldmann, T.A., Taniguchi, T., Taki, S. & Yokochi Fukuda, T. (1998) Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature, 391, 700-703.
32. Onu, A., Pohl, T., Krause, H. & Bulfone Paus, S. (1997) Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. Journal of Immunology, 158, 255-262.
33. Ruchatz, H., Leung, B.P., Wei, X.Q., McInnes, I.B. & Liew, F.Y. (1998) Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. Journal of Immunology, 160, 5654-5660.
34. Sawamura, M., Murakami, H. & Tsuchiya, J. (1996) Tumor necrosis factor-alpha and interleukin 4 in myeloma cell precursor differentiation. Leukemia and Lymphoma, 21, 31-36.
35. Söderberg, O., Christiansen, I., Nilsson, G., Carlsson, M. & Nilsson, K. (1997) Interleukin-15+thioredoxin induce DNA synthesis in B-chronic lymphocytic leukaemia cells but not in normal B cells. Leukemia, 11, 1298-1304.
36. Tagaya, Y., Kurys, G., Thies, T.A., Losi, J.M., Azimi, N., Hanover, J.A., Bamford, R.N. & Waldmann, T.A. (1997) Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides. Proceedings of the National Academy of Sciences of the United States of America, 94, 14444-14449.
37. Tortolani, P.J., Lal, B.K., Riva, A., Johnston, J.A., Chen, Y.Q., Reaman, G.H., Beckwith, M., Longo, D., Ortaldo, J.R., Bhatia, K., McGrath, I., Kehrl, J., Tuscano, J., McVirar, D.W. & O'Shea, J.J. (1995) Regulation of JAK3 expression and activation in human B cells and B cell malignancies. Journal of Immunology, 155, 5220-5226.
38. Trentin, L., Cerutti, A., Zambello, R., Sancretta, R., Tassinari, C., Facco, M., Adami, F., Rodeghiero, F., Agostini, C. & Semenzato, G. (1996) Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders. Blood, 87, 3327-3335.
39. van Zaanen, H.C.T., Lokhorst, H.M., van Aarden, L.A., Rensink, H.J.A.M., Warnaar, S.O., van der Lelie, J. & van Oers, M.H.J. (1998) Chimaeric anti-interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose-escalating study. British Journal of Haematology, 102, 783-790.
40. Waldmann, T., Tagaya, Y. & Bamford, R. (1998) Interleukin-2, interleukin-15, and their receptors. International Review of Immunology, 16, 205-226.
41. Xu, F., Gardner, A., Tu, Y., Michl, P., Prager, D. & Lichtenstein, A. (1997) Multiple myeloma cells are protected against dexamethasone-induced apoptosis by insulin-like growth factors. British Journal of Haematology, 97, 429-440.
42. Yamada, Y., Sugawara, K., Hata, T., Tsuruta, K., Moriuchi, R., Maeda, T., Atogami, S., Murata, K., Fujimoto, K., Kohno, T., Tsukasaki, K., Tomonaga, M., Hirakata, Y. & Kamihira, S. (1998) Interleukin-15 (IL-15) can replace the IL-2 signal in IL-2-dependent adult T-cell leukemia (ATL) cell lines: expression of IL-15 receptor alpha on ATL cells. Blood, 91, 4265-4272.
43. Yu, C.R., Young, H.A. & Ortaldo, J.R. (1998) Characterization of cytokine differential induction of STAT complexes in primary human T and NK cells. Journal of Leukocyte Biology, 64, 245-258.
44. Zambello, R., Facco, M., Trentin, L., Sancetta, R., Tassinari, C., Perin, A., Milani, A., Pizzolo, G., Rodeghiero, F., Agostini, C., Meazza, R., Ferrini, S. & Semenzato, G. (1997) Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood, 89, 201-211.
45. Zhang, X.G., Gu, J.J., Lu, Z.Y., Yasukawa, K., Yancopoulos, G.D., Turner, K., Shoyab, M., Taga, T., Kishimoto, T., Bataille, R. & Klein, B. (1994) Ciliary neurotropic factor, interleukin 11, leukaemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. Journal of Experimental Medicine, 179, 1337-1342.
46. Zhang, X.G., Klein, B. & Bataille, R. (1989) Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. Blood, 74, 11-13.